<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35476648</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1528-0020</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>27</Day>
            </PubDate>
          </JournalIssue>
          <Title>Blood</Title>
          <ISOAbbreviation>Blood</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib and acalabrutinib treated patients.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">blood.2021015132</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1182/blood.2021015132</ELocationID>
        <Abstract>
          <AbstractText>Ibrutinib and acalabrutinib are Bruton's tyrosine kinase inhibitors (BTKis) that are effective therapies for chronic lymphocytic leukemia (CLL). While clonal evolution during ibrutinib treatment has been investigated, the impact of clonal evolution during acalabrutinib treatment is unknown. We collected B-cell samples from 39 individuals receiving BTKi treatment annually for 3 years, with an additional sample taken at the most recent visit during the study period. Using this longitudinal data, we have reconstructed the clonal evolution of each patient using somatic mutations found within the B-cell populations. Three distinct patterns of clonal evolution were identified: 1. new clone emergence; 2. clonal selection; 3. clonal replacement. As previously seen in patients treated with ibrutinib, the evolution of subclones containing CLL-driver mutations is significantly associated with negative outcomes for patients treated with acalabrutinib (Log-rank p=0.04). Subclones containing C481S BTK mutations (a well-known resistance mechanism) developed in three patients from each BTKi cohort in a median of 3 years (range=2-3.5). Understanding the clonal evolution within patients treated with either of these BTKis can help determine how well a patient maintains response to treatment and if BTKi treatment should be modified or another agent should be added to deepen response.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022 American Society of Hematology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Black</LastName>
            <ForeName>Gage S</ForeName>
            <Initials>GS</Initials>
            <Identifier Source="ORCID">0000-0003-2086-5266</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Utah, Salt Lake City, Utah, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xiaomeng</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>University of Utah, Salt Lake City, Utah, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qiao</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Eccles Institute of Human Genetics, The University of Utah.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tarapcsak</LastName>
            <ForeName>Szabolcs</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-7182-0135</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Utah, Salt Lake City, Utah, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rogers</LastName>
            <ForeName>Kerry A</ForeName>
            <Initials>KA</Initials>
            <Identifier Source="ORCID">0000-0001-5748-7874</Identifier>
            <AffiliationInfo>
              <Affiliation>Ohio State University, Columbus, Ohio, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Misra</LastName>
            <ForeName>Shrilekha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>The Ohio State University, Columbus, Ohio, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Byrd</LastName>
            <ForeName>John C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Cincinnati, Cincinnati, Ohio, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marth</LastName>
            <ForeName>Gabor T</ForeName>
            <Initials>GT</Initials>
            <AffiliationInfo>
              <Affiliation>University of Utah, Salt Lake City, Utah, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stephens</LastName>
            <ForeName>Deborah M</ForeName>
            <Initials>DM</Initials>
            <Identifier Source="ORCID">0000-0001-9188-5008</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Utah, Salt Lake City, Utah, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Woyach</LastName>
            <ForeName>Jennifer A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Blood</MedlineTA>
        <NlmUniqueID>7603509</NlmUniqueID>
        <ISSNLinking>0006-4971</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>17</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35476648</ArticleId>
        <ArticleId IdType="doi">10.1182/blood.2021015132</ArticleId>
        <ArticleId IdType="pii">S0006-4971(22)00581-X</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
